FIGURE 2.
Virologic outcomes. A, FDA Snapshot algorithm. B, Treatment differences based on prespecified subgroups at week 24: HIV-1 RNA <50 copies/mL. C, Virologic outcomes at weeks 24 and 48 by baseline resistance profile.
Virologic outcomes. A, FDA Snapshot algorithm. B, Treatment differences based on prespecified subgroups at week 24: HIV-1 RNA <50 copies/mL. C, Virologic outcomes at weeks 24 and 48 by baseline resistance profile.